The firm's independent fund, "Bioqube Factory Fund I," is an early stage venture capital fund dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients. The fund has a fit-for-purpose dual investment model, including special attention for "Create" projects that require additional de-risking prior to creating new ventures. The team is a mix of fund managers, sector experts, and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.